Kotak Strategic Situations India Fund II Invests in Biorad Medisys
The investment arm of Kotak Alternate Asset Managers Ltd, Kotak Strategic Situations India Fund II (KSSF II), has announced a substantial investment of up to INR 400 crore in Biorad Medisys Pvt Ltd, a medical device manufacturer.
This manufacturing company operates across various markets, including India, Latin America, Europe, Southeast Asia, and the Middle East, therefore meeting the increasing global demand for high-quality healthcare products. The company will use the investment to establish a new manufacturing plant, increase working capital, and repay debts.
Eshwar Karra, CEO, KSSF, highlighted the potential of the Indian medical devices industry which is supported by government initiatives like ‘Made in India’. He also expressed confidence in Biorad Medisys’ ability to capitalize on this growth opportunity.
Jitendra Hegde, Managing Director, Biorad Medisys Pvt Lt, emphasized the company’s commitment to scaling the business further by focusing on sustainable value creation, delivering high-quality, and impeccable performance.